All Stories

  1. Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain

    Article • Journal of Immunology Research, January 2018, Hindawi Publishing Corporation

    Professor Cecil Czerkinsky

  2. Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea

    Article • Clinical and Vaccine Immunology, May 2016, ASM Journals

    Professor Cecil Czerkinsky

  3. Vaccines against enteric infections for the developing world

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, May 2015, Royal Society Publishing

    Professor Cecil Czerkinsky

  4. Shigella Outer Membrane Protein PSSP-1 Is Broadly Protective against Shigella Infection

    Article • Clinical and Vaccine Immunology, February 2015, ASM Journals

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  5. Buccal and sublingual vaccine delivery

    Article • Journal of Controlled Release, September 2014, Elsevier

    Professor Cecil Czerkinsky

  6. Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells

    Article • Mucosal Immunology, June 2013, Springer Science + Business Media

    Professor Cecil Czerkinsky

  7. Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood

    Article • Nature Protocols, May 2013, Springer Science + Business Media

    Professor Cecil Czerkinsky

  8. Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model

    Article • Mucosal Immunology, November 2012, Springer Science + Business Media

    Professor Cecil Czerkinsky

  9. B cell and T cell immunity in the female genital tract: Potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells

    Article • Clinical Microbiology and Infection, October 2012, Elsevier

    Professor Cecil Czerkinsky

  10. Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice

    Article • PLoS ONE, June 2012, PLOS

    Dr Huan H Nguyen, Professor Cecil Czerkinsky

  11. Editorial overview

    Article • Current Opinion in Immunology, June 2012, Elsevier

    Professor Cecil Czerkinsky

  12. Effect of Maternal Immune Status on Responsiveness of Bacillus Calmette-Guérin Vaccination in Mouse Neonates

    Article • Osong Public Health and Research Perspectives, June 2012, Elsevier

    Professor Cecil Czerkinsky

  13. B Lymphocytes Treated In Vitro with Antigen Coupled to Cholera Toxin B Subunit Induce Antigen-Specific Foxp3+ Regulatory T Cells and Protect against Experimental Autoimmune Encephalomyelitis

    Article • The Journal of Immunology, January 2012, The American Association of Immunologists

    Professor Cecil Czerkinsky

  14. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain

    Article • Virology Journal, January 2012, Springer Science + Business Media

    Professor Cecil Czerkinsky

  15. Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza

    Article • PLoS ONE, November 2011, PLOS

    Dr Huan H Nguyen, Professor Cecil Czerkinsky

  16. Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission

    Article • Vaccine, October 2011, Elsevier

    Professor Cecil Czerkinsky

  17. Mucosal immunity to poliovirus

    Article • Expert Review of Vaccines, October 2011, Taylor & Francis

    Professor Cecil Czerkinsky

  18. Evidence for several waves of global transmission in the seventh cholera pandemic

    Article • Nature, August 2011, Springer Science + Business Media

    Professor Julian Parkhill, Professor Dong Wook Kim, Professor Cecil Czerkinsky, James Wood

  19. Enteric vaccines for the developing world: challenges and prospects

    Article • BMC Proceedings, January 2011, Springer Science + Business Media

    Professor Cecil Czerkinsky

  20. Sublingual vaccination

    Article • Human Vaccines, January 2011, Taylor & Francis

    Professor Cecil Czerkinsky

  21. Topical immunization strategies

    Article • Mucosal Immunology, September 2010, Springer Science + Business Media

    Professor Cecil Czerkinsky

  22. Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach

    Article • Infection and Immunity, August 2010, ASM Journals

    Professor Cecil Czerkinsky

  23. A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers

    Article • Vaccine, August 2010, Elsevier

    Professor Cecil Czerkinsky

  24. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract

    Article • Vaccine, August 2010, Elsevier

    Professor Cecil Czerkinsky

  25. Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice

    Article • PLoS ONE, April 2010, PLOS

    Dr Huan H Nguyen, Professor Cecil Czerkinsky, Dr. Paul E Kilgore, Dr Hoa Do

  26. Langerhans Cells Prime IL-17-Producing T Cells and Dampen Genital Cytotoxic Responses following Mucosal Immunization

    Article • The Journal of Immunology, March 2010, The American Association of Immunologists

    Professor Cecil Czerkinsky

  27. Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B

    Article • Journal of Medical Microbiology, March 2010, Society for General Microbiology

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  28. Mucosal Delivery Routes for Optimal Immunization: Targeting Immunity to the Right Tissues

    Article • January 2010, Springer Science + Business Media

    Professor Cecil Czerkinsky

  29. Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit

    Article • Scandinavian Journal of Immunology, January 2010, Wiley

    Professor Cecil Czerkinsky

  30. Classical RS1 and environmental RS1 elements in Vibrio cholerae O1 El Tor strains harbouring a tandem repeat of CTX prophage: revisiting Mozambique in 2005

    Article • Journal of Medical Microbiology, December 2009, Society for General Microbiology

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  31. Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure

    Article • The Journal of Microbiology, December 2009, Springer Science + Business Media

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  32. Sublingual Immunization with Nonreplicating Antigens Induces Antibody-Forming Cells and Cytotoxic T Cells in the Female Genital Tract Mucosa and Protects against Genital Papillomavirus Infection

    Article • The Journal of Immunology, November 2009, The American Association of Immunologists

    Professor Cecil Czerkinsky

  33. Physical and Chemical Characterization and Immunologic Properties of Salmonella enterica Serovar Typhi Capsular Polysaccharide-Diphtheria Toxoid Conjugates

    Article • Clinical and Vaccine Immunology, November 2009, ASM Journals

    Professor Cecil Czerkinsky

  34. CCR7-CCL19/CCL21-Regulated Dendritic Cells Are Responsible for Effectiveness of Sublingual Vaccination

    Article • The Journal of Immunology, May 2009, The American Association of Immunologists

    Professor Cecil Czerkinsky

  35. Enteric vaccines for the developing world: a challenge for mucosal immunology

    Article • Mucosal Immunology, May 2009, Springer Science + Business Media

    Professor Cecil Czerkinsky

  36. Cholera Outbreaks Caused by an Altered Vibrio cholerae O1 El Tor Biotype Strain Producing Classical Cholera Toxin B in Vietnam in 2007 to 2008

    Article • Journal of Clinical Microbiology, March 2009, ASM Journals

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  37. B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit

    Article • The Journal of Immunology, December 2008, The American Association of Immunologists

    Professor Cecil Czerkinsky

  38. Oral immunization: an update

    Article • Current Opinion in Gastroenterology, November 2008, Wolters Kluwer Health

    Dr Huan H Nguyen, Professor Cecil Czerkinsky

  39. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Professor Cecil Czerkinsky

  40. Sensitization and development of tolerance via the gut

    Article • Pediatric Allergy and Immunology, June 2008, Wiley

    Professor Cecil Czerkinsky, Professor Staffan Ahlstedt

  41. Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination

    Article • Clinical & Experimental Immunology, June 2008, Wiley

    Professor Cecil Czerkinsky

  42. Sublingual vaccination with influenza virus protects mice against lethal viral infection

    Article • Proceedings of the National Academy of Sciences, February 2008, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  43. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

    Article • Vaccine, December 2007, Elsevier

    Professor Cecil Czerkinsky

  44. Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries

    Article • Journal of Medical Microbiology, November 2007, Society for General Microbiology

    Professor Dong Wook Kim, Professor Cecil Czerkinsky

  45. Sublingual ?Oral Tolerance? Induction with Antigen Conjugated to Cholera Toxin B Subunit Generates Regulatory T Cells that Induce Apoptosis and Depletion of Effector T Cells

    Article • Scandinavian Journal of Immunology, August 2007, Wiley

    Professor Cecil Czerkinsky

  46. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a

    Article • Vaccine, June 2007, Elsevier

    Professor Cecil Czerkinsky

  47. Immunité muqueuse et vaccination

    Article • médecine/sciences, April 2007, EDP Sciences

    Professor Cecil Czerkinsky

  48. Sublingual Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Induces Foxp3+CD25+CD4+ Regulatory T Cells and Suppresses Delayed-Type Hypersensitivity Reactions

    Article • Scandinavian Journal of Immunology, September 2006, Wiley

    Professor Cecil Czerkinsky

  49. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells

    Article • Immunology, July 2006, Wiley

    Professor Cecil Czerkinsky

  50. Transepithelial immunomodulation by cholera toxin and non-toxic derivatives

    Article • Vaccine, April 2006, Elsevier

    Professor Cecil Czerkinsky

  51. Dendritic Cell-Mediated Induction of Mucosal Cytotoxic Responses following Intravaginal Immunization with the Nontoxic B Subunit of Cholera Toxin

    Article • The Journal of Immunology, February 2006, The American Association of Immunologists

    Professor Cecil Czerkinsky

  52. Mucosal adjuvants based on cholera toxin and E. coli heat-labile enterotoxin

    Article • January 2006, Elsevier

    Professor Cecil Czerkinsky

  53. The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties

    Article • Vaccine, April 2005, Elsevier

    Professor Cecil Czerkinsky

  54. Mucosal immunity and vaccines

    Article • Nature Medicine, April 2005, Springer Science + Business Media

    Professor Cecil Czerkinsky

  55. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

    Article • Immunology Letters, March 2005, Elsevier

    Professor Cecil Czerkinsky

  56. Mucosal Vaccines

    Article • January 2005, Elsevier

    Professor Cecil Czerkinsky

  57. Inhibition de la transcytose du VIH in vitro par des immunoglobulines de type A sécrétoires spécifiques de l’épitope ELDKWA obtenues après vaccination muqueuse chez la souris

    Article • Annales de Pathologie, November 2004, Elsevier

    Professor Cecil Czerkinsky

  58. In Vivo Adjuvant-Induced Mobilization and Maturation of Gut Dendritic Cells after Oral Administration of Cholera Toxin

    Article • The Journal of Immunology, October 2004, The American Association of Immunologists

    Professor Cecil Czerkinsky

  59. Current status and future prospects for a vaccine against schistosomiasis

    Article • Expert Review of Vaccines, June 2004, Taylor & Francis

    Professor Cecil Czerkinsky

  60. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

    Article • Vaccine, June 2003, Elsevier

    Professor Cecil Czerkinsky

  61. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

    Article • Expert Review of Vaccines, April 2003, Taylor & Francis

    Professor Cecil Czerkinsky

  62. Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses

    Article • The Journal of Immunology, February 2003, The American Association of Immunologists

    Professor Cecil Czerkinsky

  63. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection

    Article • Vaccine, January 2003, Elsevier

    Professor Cecil Czerkinsky

  64. α4 Integrins and L-selectin Differently Orchestrate T-cell Activity During Diabetes Prevention Following Oral Administration of CTB-insulin

    Article • Journal of Autoimmunity, December 2002, Elsevier

    Professor Cecil Czerkinsky

  65. Nasal Administration of Schistosoma mansoni Egg Antigen-Cholera B Subunit Conjugate Suppresses Hepatic Granuloma Formation and Reduces Mortality in S. mansoni -Infected Mice

    Article • Scandinavian Journal of Immunology, November 2001, Wiley

    Professor Cecil Czerkinsky

  66. Local and Systemic Immune Responses to Rectal Administration of Recombinant Cholera Toxin B Subunit in Humans

    Article • Infection and Immunity, June 2001, ASM Journals

    Professor Cecil Czerkinsky

  67. Nasal administration of Schistosoma Mansoni egg antigens-cholera toxin B subunit conjugate to infected mice reduces immunopathology and mortality

    Article • January 2001, Springer Science + Business Media

    Professor Cecil Czerkinsky

  68. Enhanced Immunological Tolerance against Allograft Rejection by Oral Administration of Allogeneic Antigen Linked to Cholera Toxin B Subunit

    Article • Clinical Immunology, November 2000, Elsevier

    Professor Cecil Czerkinsky

  69. Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells

    Article • Clinical & Experimental Immunology, August 2000, Wiley

    Professor Cecil Czerkinsky

  70. Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co‐administration with free toxin as adjuvant

    Article • Apmis, January 2000, Wiley

    Professor Cecil Czerkinsky

  71. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells

    Article • Diabetes, November 1999, American Diabetes Association

    Professor Cecil Czerkinsky

  72. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine

    Article • Arthritis & Rheumatism, August 1999, Wiley

    Professor Cecil Czerkinsky

  73. Mucosal immunity and tolerance: relevance to vaccine development

    Article • Immunological Reviews, August 1999, Wiley

    Professor Cecil Czerkinsky

  74. Oral Tolerance and Anti-Pathological Vaccines

    Article • January 1999, Springer Science + Business Media

    Professor Cecil Czerkinsky

  75. The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo

    Article • Clinical & Experimental Immunology, September 1998, Wiley

    Professor Cecil Czerkinsky

  76. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate

    Article • European Journal of Immunology, February 1998, Wiley

    Professor Cecil Czerkinsky

  77. Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate

    Article • European Journal of Immunology, February 1998, Wiley

    Professor Cecil Czerkinsky

  78. Induction and Expression of Intestinal Humoral Immunity in HIV-Infected Individuals: Prospects for Vaccination against Secondary Enteric Infections

    Article • Pathobiology, January 1998, Karger Publishers

    Professor Cecil Czerkinsky

  79. New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines

    Article • Research in Immunology, January 1998, Elsevier

    Professor Cecil Czerkinsky

  80. Suppression of Delayed‐Type Contact Sensitivity in the Murine Oral Mucosa by Prior Intragastric Administration of Hapten

    Article • Scandinavian Journal of Immunology, September 1997, Wiley

    Professor Cecil Czerkinsky

  81. Visualization of tissue distribution of MHC-associated antigens in vivo

    Article • Immunology Letters, May 1997, Elsevier

    Professor Cecil Czerkinsky

  82. “PERFEXT”: a direct method for quantitative assessment of cytokine production in vivo at the local level

    Article • Research in Immunology, May 1997, Elsevier

    Professor Cecil Czerkinsky

  83. Immunogenic and tolerogenic properties of mucosal administrated antigens linked to cholera and E. Coli heat-labile enterotoxin B subunits: A comparative study

    Article • Immunology Letters, May 1997, Elsevier

    Professor Cecil Czerkinsky

  84. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

    Article • Proceedings of the National Academy of Sciences, April 1997, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  85. Combined immunomagnetic cell sorting and ELISPOT assay for the phenotypic characterization of specific antibody-forming cells

    Article • Journal of Immunological Methods, April 1997, Elsevier

    Professor Cecil Czerkinsky

  86. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.

    Article • Journal of Clinical Investigation, March 1997, American Society for Clinical Investigation

    Professor Cecil Czerkinsky

  87. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

    Article • Proceedings of the National Academy of Sciences, July 1996, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  88. Histaminergic regulation of interferon‐gamma (IFN‐γ) production by human natural killer (NK) cells

    Article • Clinical & Experimental Immunology, July 1996, Wiley

    Professor Cecil Czerkinsky

  89. Antigen presentation in the murine oral epithelium

    Article • Immunology, May 1996, Wiley

    Professor Cecil Czerkinsky

  90. Experimental T cell-mediated inflammatory reactions in the murine oral mucosa. II. Immunohistochemical characterization of resident and infiltrating cells

    Article • Clinical & Experimental Immunology, May 1996, Wiley

    Professor Cecil Czerkinsky

  91. Cholera Toxin B Subunit as Transmucosal Carrier-Delivery and Immunomodulating System for Induction of Antiinfectious and Antipathological Immunitya

    Article • Annals of the New York Academy of Sciences, February 1996, Wiley

    Professor Cecil Czerkinsky

  92. Consideration of Mucosally Induced Tolerance in Vaccine Development

    Article • January 1996, Elsevier

    Professor Cecil Czerkinsky

  93. Generalized and Compartmentalized Mucosal Immune Responses in Humans

    Article • January 1996, Elsevier

    Professor Cecil Czerkinsky

  94. Cholera and Oral-Mucosal Anti-infectious and Anti-inflammatory Vaccines

    Article • January 1996, Elsevier

    Professor Cecil Czerkinsky

  95. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals

    Article • AIDS, July 1995, Wolters Kluwer Health

    Professor Cecil Czerkinsky

  96. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers

    Article • European Journal of Immunology, February 1995, Wiley

    Professor Cecil Czerkinsky

  97. Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

    Article • Proceedings of the National Academy of Sciences, December 1994, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  98. Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

    Article • Proceedings of the National Academy of Sciences, November 1994, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  99. Intestinal antibody responses to oral vaccination in HIV-infected individuals

    Article • AIDS, August 1993, Wolters Kluwer Health

    Professor Cecil Czerkinsky

  100. Immunoglobulin secretion by the normal and the infected newborn infant

    Article • The Journal of Pediatrics, May 1993, Elsevier

    Professor Cecil Czerkinsky

  101. Induction and Assessment of Immunity at Enteromucosal Surfaces in Humans: Implications for Vaccine Development

    Article • Clinical Infectious Diseases, March 1993, Oxford University Press (OUP)

    Professor Cecil Czerkinsky

  102. Role of Serotonin in the Regulation of Interferon-γ Production by Human Natural Killer Cells

    Article • Journal of Interferon Research, February 1993, Mary Ann Liebert Inc

    Professor Cecil Czerkinsky

  103. Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systems

    Article • Vaccine, January 1993, Elsevier

    Professor Cecil Czerkinsky

  104. Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptides

    Article • Vaccine, January 1993, Elsevier

    Professor Cecil Czerkinsky

  105. Cholera as a model for research on mucosal immunity and development of oral vaccines

    Article • Current Biology, October 1992, Elsevier

    Professor Cecil Czerkinsky

  106. Secretory immunoglobulins in serum from human immunodeficiency virus (HIV)-infected patients

    Article • Journal of Clinical Immunology, September 1992, Springer Science + Business Media

    Professor Cecil Czerkinsky

  107. Amplified ELISPOT assay for the detection of HIV-specific antibody-secreting cells in subhuman primates

    Article • Journal of Immunological Methods, August 1992, Elsevier

    Professor Cecil Czerkinsky

  108. Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay

    Article • Journal of Immunological Methods, June 1992, Elsevier

    Professor Cecil Czerkinsky

  109. Mucosal Immunity: Implications for Vaccine Development

    Article • Immunobiology, February 1992, Elsevier

    Professor Cecil Czerkinsky

  110. Cholera as a model for research on mucosal immunity and development of oral vaccines

    Article • Current Opinion in Immunology, January 1992, Elsevier

    Professor Cecil Czerkinsky

  111. Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensitivity reactions at mucosal surfaces

    Article • Clinical & Experimental Immunology, December 1991, Wiley

    Professor Cecil Czerkinsky

  112. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.

    Article • Proceedings of the National Academy of Sciences, December 1991, Proceedings of the National Academy of Sciences

    Professor Cecil Czerkinsky

  113. Enumeration of human peripheral blood lymphocytes secreting immunoglobulins of major classes and subclasses in healthy children and adults

    Article • Journal of Clinical Immunology, July 1991, Springer Science + Business Media

    Professor Cecil Czerkinsky

  114. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

    Article • Journal of Clinical Investigation, July 1991, American Society for Clinical Investigation

    Professor Cecil Czerkinsky

  115. Normal and abnormal mucosal antibody mediated immunity

    Article • Clinical & Experimental Allergy, May 1991, Wiley

    Professor Cecil Czerkinsky

  116. Detection of Human Cytokine-Secreting Cells in Distinct Anatomical Compartments

    Article • Immunological Reviews, February 1991, Wiley

    Professor Cecil Czerkinsky

  117. IgA-Secreting Cells in the Blood of Premature and Term Infants: Normal Development and Effect of Intrauterine Infections

    Article • January 1991, Springer Science + Business Media

    Professor Cecil Czerkinsky

  118. Induction of human secretory and serum immune responses: molecular properties of IgA antibodies

    Article • January 1990, Springer Science + Business Media

    Professor Michael W Russell, Professor Cecil Czerkinsky

  119. Peyer’s patches immunization with Streptococcus mutans in rats induces predominantly IgG antibodies in saliva

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  120. Thermolysin treatment; an improved dispersion technique for isolating functional lymphoid cells from intestinal tissues

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  121. Spontaneous gamma-interferon production by human tonsillar lymphocytes: regulation of secretion by interleukin-1

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  122. Contact sensitivity in the murine oral mucosa: an experimental model of delayed type hypersensitivity at mucosal surfaces

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  123. Expansion of gamma-interferon producing cell populations in the intestinal mucosa after peroral immunisation in humans

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  124. Lymphoid cell populations dynamics and the mucosal immune response in humans

    Article • January 1990, Springer Science + Business Media

    Professor Cecil Czerkinsky

  125. ELISPOT: A New Approach to Studying the Dynamics of Virus-Immune System Interaction for Diagnosis and Monitoring of HIV Infection

    Article • AIDS Research and Human Retroviruses, October 1989, Mary Ann Liebert Inc

    Professor Cecil Czerkinsky

  126. Kinetics and Isotype Distribution of Parasite-Specific Antibody Responses in the Spleen of Mice during Primary Infection with Schistosoma mansoni

    Article • International Archives of Allergy and Immunology, January 1989, Karger Publishers

    Professor Cecil Czerkinsky

  127. Oral lesions of lupus erythematosus patients in relation to other chronic inflammatory oral diseases: an immunologic study

    Article • European Journal Of Oral Sciences, December 1988, Wiley

    Professor Cecil Czerkinsky

  128. A novel two colour ELISPOT assay

    Article • Journal of Immunological Methods, November 1988, Elsevier

    Professor Cecil Czerkinsky

  129. Binding of IgA to erythrocytes from patients with IgA nephropathy

    Article • Clinical Immunology and Immunopathology, July 1988, Elsevier

    Professor Cecil Czerkinsky

  130. Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

    Article • Journal of Immunological Methods, May 1988, Elsevier

    Professor Cecil Czerkinsky

  131. Striking Elevation of Serum IgA, IgA-Containing Immune Complexes, and IgA Rheumatoid Factor in Clinically Silent Dermatitis Herpetiformis

    Article • American Journal of Kidney Diseases, November 1987, Elsevier

    Professor Michael W Russell, Professor Cecil Czerkinsky

  132. Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies

    Article • Clinical Immunology and Immunopathology, November 1987, Elsevier

    Professor Cecil Czerkinsky

  133. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans.

    Article • Proceedings of the National Academy of Sciences, April 1987, Proceedings of the National Academy of Sciences

    Professor Michael W Russell, Professor Cecil Czerkinsky

  134. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.

    Article • Journal of Clinical Investigation, June 1986, American Society for Clinical Investigation

    Professor Cecil Czerkinsky

  135. Dissociation of antibodies bound to surface-immobilized antigen

    Article • Journal of Immunological Methods, December 1985, Elsevier

    Professor Cecil Czerkinsky

  136. Solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of IgG rheumatoid factor-secreting cells

    Article • Journal of Immunological Methods, September 1984, Elsevier

    Professor Cecil Czerkinsky

  137. Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances

    Article • Journal of Immunological Methods, September 1984, Elsevier

    Professor Cecil Czerkinsky

  138. An Immunoenzyme Procedure for Enumerating Fibronectin-Secreting Cells

    Article • Journal of Immunoassay, September 1984, Taylor & Francis

    Professor Cecil Czerkinsky

  139. Detection of Single Antibody-Secreting Cells Generated After in Vitro Antigen-Induced Stimulation of Human Peripheral Blood Lymphocytes

    Article • Scandinavian Journal of Immunology, June 1984, Wiley

    Professor Cecil Czerkinsky

  140. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

    Article • Journal of Immunological Methods, December 1983, Elsevier

    Professor Cecil Czerkinsky

  141. 3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin

    Article • De Gruyter

    Professor Cecil Czerkinsky